Aspen Neuroscience, Inc. Common Stock

ASPENASDAQ • USD
12.59 USD
↘ 1.02 (7.49%)AT CLOSE (03:59 PM EST)
12.24
↘ 0.35 (2.77%)
POST MARKET (AS OF 04:10 PM EST)
Post Market
AS OF 04:10 PM EST
12.24
↘ 0.35 (2.77%)
🟢Market: OPEN

ASPE is currently priced at $12.24. The technical outlook is "Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include a bullish Golden Cross on the moving averages.

Technical & fundamental data as of Nov 12, 2026.

Open?$14.00
High?$14.07
Low?$12.07
Prev. Close?$13.61
Volume?173.3K
Avg. Volume?N/A
VWAP?$12.80
Bid / Ask
Bid?$10.70 × 100
Ask?$16.08 × 100
Spread?$5.38
Midpoint?$13.39
Valuation & Ratios
Market Cap?395.8M
Shares Out?N/A
Float?6.5M
Float %?22.2%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Aspen Neuroscience Inc is a clinical-stage, regenerative medicine biotechnology company focused on developing autologous induced-pluripotent stem cell (iPSC)-derived therapies to initially address neurodegenerative diseases with high unmet medical need. The company's flagship program, sasineprocel, is an investigational autologous iPSC-based therapy for Parkinson's disease designed to replace a patient's lost dopamine neurons with dopaminergic neuron precursor cells.
Employees
N/A
Market Cap
395.8M
Industry
N/A
Listed
2026-10-30
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short Interest
Loading...